WENDY SURA: Open Payments
NPI 1366580201 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 7 payments from 6 companies in 2025. Trend: 2023 $20 · 2024 $75 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Fabhalta, Enhertu, JEMPERLI, LYNOZYFIC, MONOFERRIC.
Industry payments across CA — which companies pay providers there.
